Valuation: Steris PLC

Market Cap 24.17B 21.54B 19.7B 17.94B 33.82B 2,284B 34.73B 237B 94.64B 1,210B 90.73B 88.78B 3,817B P/E 2027 *
27.4x
P/E 2028 * 24.4x
Enterprise Value 25.56B 22.78B 20.84B 18.98B 35.77B 2,416B 36.73B 250B 100B 1,279B 95.96B 93.9B 4,037B EV / Sales 2027 *
4.01x
EV / Sales 2028 * 3.69x
Free-Float
99.7%
Yield 2027 *
1.07%
Yield 2028 * 1.16%
Manager TitleAgeSince
Chief Executive Officer 53 28/07/2021
Director of Finance/CFO 59 17/08/2025
Compliance Officer - 31/07/2019
Director TitleAgeSince
Director/Board Member 73 28/02/2005
Director/Board Member 54 30/04/2018
Chairman 67 27/07/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%+3.19% - - 24.17B
-1.65%+8.64%-8.78%+19.58% 200B
-0.11%+7.96%+15.97%+42.79% 128B
-1.35%+7.48%-6.32%+21.04% 129B
+1.51%+8.02%-39.33%+10.16% 97.53B
-4.05%+2.77%-4.05%+72.53% 67.55B
+2.08%+7.67%+21.07%-17.58% 56.98B
-3.99%+16.45%-6.87%+58.55% 55.04B
-1.39%-8.86%-4.24%+57.30% 51.24B
-0.79%+8.92%+3.39%-6.33% 37.43B
Average -0.92%+8.84%-3.24%+28.67% 91.49B
Weighted average by Cap. -1.10%+9.79%-4.73%+27.86%

Financials

2027 *2028 *
Net sales 6.38B 5.68B 5.2B 4.74B 8.93B 603B 9.17B 62.46B 24.98B 319B 23.94B 23.43B 1,007B 6.81B 6.07B 5.55B 5.05B 9.53B 643B 9.78B 66.66B 26.66B 341B 25.55B 25.01B 1,075B
Net income 889M 792M 725M 660M 1.24B 84.01B 1.28B 8.7B 3.48B 44.49B 3.34B 3.27B 140B 990M 882M 807M 735M 1.38B 93.52B 1.42B 9.69B 3.87B 49.53B 3.71B 3.63B 156B
Net Debt 1.39B 1.24B 1.14B 1.03B 1.95B 132B 2B 13.65B 5.46B 69.75B 5.23B 5.12B 220B 960M 856M 783M 713M 1.34B 90.73B 1.38B 9.4B 3.76B 48.05B 3.6B 3.53B 152B
Logo Steris PLC
STERIS plc is one of the world's leading suppliers of sterilisation solutions and medical equipment. Net sales by business area break down as follows: - sale of sterilisation solutions and surgical equipment (70.9%): primarily cleaning products, accessories for gastrointestinal surgery, washers, sterilisers, surgical tables, lighting systems, etc. In addition, the group offers equipment repair and maintenance services; - development of sterilisation solutions (19.2%): sterilisation services, laboratory testing, and product and packaging testing for manufacturers of medical devices and pharmaceutical products; - sales of consumables and equipment (9.9%): for biopharmaceutical companies and manufacturers of medical devices. Net sales by source of income break down into sales of equipment (51.5%) and services (48.5%). Net sales are distributed geographically as follows: Ireland (1.8%), the United States (73%) and other (25.2%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Steris PLC